Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has released its financial results for the fourth quarter and year-ended October 31, 2022.
Saviuk telling Proactive the company saw record quarterly revenues of 12.7 million dollars in Q4 2022 which is up 274% year over year. Valeo also saw record annual revenues of 27.7 million for 2022, compared to $13.6 million in 2021, up 105%.
Saviuk also shared more details about what has led the company in revenue and what is planned in 2023 to fuel the momentum.
#proactiveinvestors #valeopharmainc #tsx #vph #otcqb #vphif #pharma
#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews